Correlation Between Crinetics Pharmaceuticals and Telix Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crinetics Pharmaceuticals and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Telix Pharmaceuticals.

Diversification Opportunities for Crinetics Pharmaceuticals and Telix Pharmaceuticals

0.06

Correlation Coefficient

Crinetics Pharmaceuticals  Telix Pharmaceuticals

Significant diversification

The 3 months correlation between Crinetics and Telix is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Telix Pharmaceuticals

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 1.36 times more return on investment than Telix Pharmaceuticals. However, Crinetics Pharmaceuticals is 1.36 times more volatile than Telix Pharmaceuticals Limited. It trades about -0.15 of its potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about -0.24 per unit of risk. If you would invest  5,887  in Crinetics Pharmaceuticals on October 7, 2024 and sell it today you would lose (572.00) from holding Crinetics Pharmaceuticals or give up 9.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Crinetics Pharmaceuticals  vs.  Telix Pharmaceuticals Limited

Crinetics Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Crinetics Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Telix Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telix Pharmaceuticals Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Telix Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Crinetics Pharmaceuticals and Telix Pharmaceuticals

The main advantage of trading using opposite Crinetics Pharmaceuticals and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.

The idea behind Crinetics Pharmaceuticals and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.